Slayback Exclusivity On Taytulla Does Not Bar Rival ANDA Product

US-Based Player Received Approval With CGT Designation

 
• By Dean Rudge

Slayback Pharma has now launched its Merzee generic version of Allergan’s Taytulla oral contraceptive with a CGT designation, several months after Xiromed moved first.

Virtual_Buttons
“CGT exclusivity is not applied retrospectively," Slayback told Generics Bulletin • Source: Shutterstock

More from Generics

More from Products